Recent research suggests a potential link between acid reflux medications and migraines. Scientists have identified a higher risk of severe headaches in individuals using acid-reducing drugs like proton pump inhibitors (PPIs) such as omeprazole and esomeprazole, histamine H2-receptor antagonists (H2 blockers) like cimetidine and famotidine, and antacid supplements.
It’s important to note that the study indicates an association rather than a direct cause-effect relationship between acid-reducing drugs and migraines. Acid reflux occurs when stomach acid moves into the esophagus, typically after eating or lying down.
Acid reflux can lead to heartburn, ulcers, and potentially gastroesophageal reflux disease (GERD), which may increase the risk of esophageal cancer. Professor Margaret Slavin from the University of Maryland emphasized the need for further investigation into the implications of acid-reducing drugs on migraines, especially considering the widespread use of these medications and the emerging risks associated with long-term use of PPIs, such as a higher risk of dementia.
A research team analyzed data from over 11,800 individuals regarding their use of prescribed acid-reducing drugs and their experience of migraines or severe headaches in the past three months. Participants taking PPIs had a 25% incidence of migraines or severe headaches, compared to 19% in those not taking the drugs. Similarly, 25% of individuals using H2 blockers and 22% using antacid supplements reported severe headaches compared to 19% and 20% respectively, in non-users.
After adjusting for various factors like age, sex, caffeine, and alcohol consumption, the study revealed that individuals taking PPIs were 70% more likely to experience migraines, while those on H2 blockers were 40% more likely, and antacid supplement users were 30% more likely. These findings were published in the journal Neurology Clinical Practice.
Professor Slavin underlined the importance of consulting healthcare providers for individuals with acid reflux or other conditions requiring acid-reducing medications, especially if they experience migraines or severe headaches.
While previous research has suggested a connection between gastrointestinal issues and migraines, the study indicates that this relationship alone may not fully explain the observed association between acid-reducing drugs and migraines.